Gary Gellerman

2.0k total citations
85 papers, 1.6k citations indexed

About

Gary Gellerman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gary Gellerman has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 30 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Gary Gellerman's work include Chemical Synthesis and Analysis (18 papers), Cancer therapeutics and mechanisms (15 papers) and Nanoplatforms for cancer theranostics (15 papers). Gary Gellerman is often cited by papers focused on Chemical Synthesis and Analysis (18 papers), Cancer therapeutics and mechanisms (15 papers) and Nanoplatforms for cancer theranostics (15 papers). Gary Gellerman collaborates with scholars based in Israel, Ukraine and Germany. Gary Gellerman's co-authors include Michael A. Firer, L. D. Patsenker, Andrii Bazylevich, Amnon Albeck, Bert W. O’Malley, David M. Lonard, Ofer Shpilberg, Yossi Gilad, Kalimuthu Kalishwaralal and Bat-Chen R. Avraham-Lubin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Biochemistry.

In The Last Decade

Gary Gellerman

80 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Gellerman Israel 22 850 389 354 322 273 85 1.6k
André Warnecke Germany 19 848 1.0× 398 1.0× 276 0.8× 456 1.4× 546 2.0× 26 1.7k
Chiyi Xiong United States 25 916 1.1× 372 1.0× 751 2.1× 248 0.8× 464 1.7× 53 2.0k
Vincent J. Venditto United States 16 808 1.0× 290 0.7× 400 1.1× 187 0.6× 600 2.2× 34 1.7k
Ehud Segal United States 21 987 1.2× 274 0.7× 543 1.5× 503 1.6× 375 1.4× 26 2.2k
Walter A. Henne United States 12 739 0.9× 187 0.5× 539 1.5× 163 0.5× 433 1.6× 15 1.5k
Yun H. Choe South Korea 13 682 0.8× 388 1.0× 285 0.8× 191 0.6× 457 1.7× 19 1.4k
Diego Tesauro Italy 23 717 0.8× 495 1.3× 195 0.6× 388 1.2× 663 2.4× 76 1.8k
Yujie Shi China 23 799 0.9× 242 0.6× 347 1.0× 220 0.7× 226 0.8× 66 1.7k
P Poučková Czechia 24 728 0.9× 194 0.5× 453 1.3× 204 0.6× 214 0.8× 102 1.9k
Daniela Arosio Italy 29 1.2k 1.4× 474 1.2× 190 0.5× 355 1.1× 306 1.1× 72 1.8k

Countries citing papers authored by Gary Gellerman

Since Specialization
Citations

This map shows the geographic impact of Gary Gellerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Gellerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Gellerman more than expected).

Fields of papers citing papers by Gary Gellerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Gellerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Gellerman. The network helps show where Gary Gellerman may publish in the future.

Co-authorship network of co-authors of Gary Gellerman

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Gellerman. A scholar is included among the top collaborators of Gary Gellerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Gellerman. Gary Gellerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zipin‐Roitman, Adi, Dror Tobi, Andrii Bazylevich, et al.. (2025). Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia. Scientific Reports. 15(1). 10607–10607. 1 indexed citations
3.
Sharma, Vipin, Andrii Bazylevich, Dror Tobi, et al.. (2024). Synthesis and anticancer properties of novel dolastatin 10 analogs featuring five-membered heterocyclic rings with a linkable group at the C-terminus. Bioorganic & Medicinal Chemistry. 109. 117794–117794. 1 indexed citations
4.
5.
Gellerman, Gary, et al.. (2024). Cyanine-saccharide conjugates for bacterial diagnostics: Towards multiplexed assays. Dyes and Pigments. 228. 112232–112232.
6.
Nakonechny, Faina, et al.. (2023). Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers. Pharmaceutics. 15(1). 247–247. 10 indexed citations
7.
Tatarets, Anatoliy L., et al.. (2023). Antibody-guided iodinated cyanine for near-IR photoimmunotherapy. Dyes and Pigments. 212. 111101–111101. 11 indexed citations
8.
9.
Nakonechny, Faina, et al.. (2022). Highly efficient near-IR cyclohexene cyanine photosensitizers for antibacterial photodynamic therapy. Dyes and Pigments. 211. 111053–111053. 14 indexed citations
10.
Bazylevich, Andrii, et al.. (2021). Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization. ACS Medicinal Chemistry Letters. 12(10). 1596–1604. 9 indexed citations
11.
Gellerman, Gary, et al.. (2021). Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells. Bioconjugate Chemistry. 32(8). 1641–1651. 10 indexed citations
12.
Sherman, Michael Y., et al.. (2021). Targeted methylation facilitates DNA double strand breaks and enhances cancer suppression: A DNA intercalating/methylating dual-action chimera Amonafidazene. European Journal of Medicinal Chemistry. 225. 113811–113811. 11 indexed citations
13.
Nakonechny, Faina, et al.. (2021). Unexpected effect of iodine atoms in heptamethine cyanine dyes on the photodynamic eradication of Gram-positive and Gram-negative pathogens. Dyes and Pigments. 195. 109745–109745. 20 indexed citations
14.
Gellerman, Gary, et al.. (2021). Quantification of Drug Release Degree In Vivo Using Antibody-Guided, Dual-NIR-Dye Ratiometric System. Analytical Chemistry. 93(23). 8265–8272. 12 indexed citations
15.
Patsenker, L. D. & Gary Gellerman. (2019). Fluorescent Reporters for Drug Delivery Monitoring. Israel Journal of Chemistry. 60(5-6). 504–518. 20 indexed citations
16.
Bazylevich, Andrii, et al.. (2019). Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery. RSC Advances. 9(56). 32656–32664. 14 indexed citations
17.
Nakonechny, Faina, et al.. (2019). Dark Antibacterial Activity of Rose Bengal. International Journal of Molecular Sciences. 20(13). 3196–3196. 30 indexed citations
18.
19.
Albeck, Amnon, et al.. (2015). Bio‐labile peptidyl delivery systems towards sequential drug release. Biopolymers. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Warnecke Breakdown of academic impact, for papers by Chiyi Xiong Breakdown of academic impact, for papers by Vincent J. Venditto Breakdown of academic impact, for papers by Ehud Segal Breakdown of academic impact, for papers by Walter A. Henne Breakdown of academic impact, for papers by Yun H. Choe Breakdown of academic impact, for papers by Diego Tesauro Breakdown of academic impact, for papers by Yujie Shi Breakdown of academic impact, for papers by P Poučková Breakdown of academic impact, for papers by Daniela Arosio
Rankless by CCL
2026